non-homologous-end-joining

Partial verification note: Walker 2001 and Riballo 1999 verified against PDFs (2026-05-05). Claims attributed to Mahaney 2009 (10.1042/BJ20080413) could not be verified — download failed despite green OA status. Affected claims: DNA-PKcs autophosphorylation cluster details (ABCDE/PQR) and XRCC4–LIG4–XLF ligation complex scaffold description in Steps 2–3. no-fulltext-access for Mahaney 2009 specifically.

Non-Homologous End Joining (NHEJ)

Non-homologous end joining (NHEJ) is the dominant double-strand break (DSB) repair pathway in mammalian cells. Unlike homologous-recombination, which requires a sister-chromatid template and is restricted to S and G2 phases, NHEJ operates throughout the cell cycle — including in G0/G1 and in post-mitotic cells such as neurons — making it the primary means of DSB repair in most adult tissues. NHEJ directly ligates broken DNA ends with minimal resection, but this speed comes at the cost of fidelity: small insertions, deletions (indels), or base substitutions are frequently introduced at the junction. NHEJ activity declines measurably with organismal age, and persistent unrepaired DSBs in post-mitotic and senescent cells are a canonical molecular signature of the genomic-instability hallmark of aging.

Pathway overview

KEGG and Reactome identifiers

Database	ID	Entry name
KEGG	hsa03450	Non-homologous end-joining — Homo sapiens
Reactome	R-HSA-5693571	Nonhomologous End-Joining (NHEJ)

KEGG hsa03450 lists 13 human genes in the pathway (including XRCC6, XRCC5, PRKDC, DCLRE1C, NHEJ1, XRCC4, LIG4, POLM, POLL, FEN1, DNTT, MRE11, RAD50). Reactome R-HSA-5693571 provides reaction-level granularity for each ligation step and is the recommended reference for mechanistic detail.

Mechanism: four sequential steps

NHEJ proceeds through four functionally distinct steps ¹²:

Step 1 — DSB recognition: Ku70–Ku80 ring loading

The Ku heterodimer (ku70-ku80; encoded by XRCC6 and XRCC5) is the first responder to a DSB. Ku forms a preformed ring-shaped structure that threads onto the broken DNA end without sequence specificity; the ring is designed with an expansive base that cradles DNA and a narrow bridge that acts as a barrier to binding unbroken (circular) DNA ³. Inward translocation of Ku from the end is the rate-limiting step for internal binding, explaining Ku’s preference for DNA termini ³. Ku’s end-occupancy shields termini from excessive nucleolytic degradation unsourced — the structural protection inference is consistent with Walker 2001 but the biochemical nuclease-protection function is demonstrated by other studies (e.g., Feldmann et al. 2000, Nucleic Acids Res 28:2585) not yet cited on this page. The Ku ring recruits dna-pkcs (encoded by PRKDC) to form the DNA-PK holoenzyme ³.

Step 2 — Synapsis and end processing: DNA-PKcs autophosphorylation and Artemis recruitment

dna-pkcs (a ~470 kDa serine/threonine kinase of the PIKK family) bridges the two broken ends to form a synaptic complex, bringing them into proximity. DNA-PKcs undergoes extensive trans-autophosphorylation (at the ABCDE and PQR clusters), which opens the DNA termini to processing enzymes ². Artemis (DCLRE1C) is a structure-specific endonuclease that is activated by direct interaction with DNA-PKcs; Artemis trims 5’ overhangs and hairpin intermediates (critical for V(D)J recombination) and is the primary nuclease for generating ligatable ends from complex DSBs ¹. Polymerases pol-mu (POLM) and pol-lambda (POLL) fill short single-stranded gaps when ends are not directly compatible; terminal deoxynucleotidyl transferase (TdT, DNTT) contributes non-templated nucleotide additions in lymphocytes (contributing to junctional diversity in V(D)J recombination) ⁴.

Step 3 — Ligation: XRCC4–LIG4–XLF complex

The ligation step is executed by a trimeric scaffold: xrcc4 (XRCC4) and xlf (NHEJ1; also called Cernunnos) each form homodimers that assemble into long filaments flanking the DNA ends; lig4 (LIG4) is the catalytic ligase, tethered to XRCC4 via its tandem BRCT domains ²⁴. LIG4 possesses a unique insert1 motif that remodels the paired-end complex and enables ligation of incompatible or partially processed termini ⁴. PAXX (C9orf142), a structural paralog of XRCC4/XLF, is a more recently identified accessory factor that stabilizes Ku at DNA ends and promotes ligation under challenging end configurations needs-replication.

Step 4 — Error profile

NHEJ frequently introduces small indels at junctions because end processing by Artemis and gap-filling polymerases may add or remove nucleotides before ligation. In contrast to homologous recombination (which restores the original sequence using a template), NHEJ is intrinsically mutagenic — an acceptable trade-off in long-lived post-mitotic cells where rapid repair outweighs the risk of somatic mutation ¹.

Cell-cycle independence

A critical distinction from homologous-recombination:

Feature	NHEJ	Homologous Recombination (HR)
Template required	No (direct ligation)	Yes (sister chromatid)
Cell-cycle phases	G0, G1, S, G2, M	S/G2 only
Post-mitotic cells	Yes (dominant pathway)	No
Fidelity	Error-prone (indels common)	High-fidelity
Key initiator	Ku70–Ku80	MRN complex + CtIP resection

NHEJ predominates in G1 due to the lack of a sister-chromatid template; it is the only DSB repair option in terminally differentiated post-mitotic cells (e.g., neurons, cardiomyocytes) ¹.

Aging relevance

Age-related decline in NHEJ activity

NHEJ capacity declines measurably with age across multiple mammalian systems. In rat neurons, NHEJ end-joining activity is “considerably lower in adult brain, and neurons from old brain failed to support significant end joining” compared with neonatal neurons — a decline blocked by the DNA-PKcs inhibitor wortmannin, implicating loss of DNA-PK kinase activity as a mechanistic driver ⁵. This is consistent with the broader observation that DSB repair efficiency in non-dividing tissues decreases with age, accumulating unrepaired breaks.

Persistent DSB foci in senescent and aging cells

Sedelnikova et al. (2004) demonstrated that both replicatively senescent human fibroblasts and aged mouse tissues (liver, spleen) accumulate DSB lesions that co-localize with γ-H2AX foci — a marker of unresolved DSBs — and that these foci persist indefinitely rather than resolving after DNA damage clearance ⁶. This persistence is consistent with a model in which NHEJ (and HR) becomes progressively insufficient to clear the full burden of spontaneous DSBs generated by reactive oxygen species, replication stress, and transcription-associated breaks over organismal lifetime.

Dimension	Status
Pathway conserved in humans?	Yes — NHEJ is universally conserved across eukaryotes
Age-related decline conserved in humans?	Partial — neuron data from rat; persistent DDR foci in human senescent cells confirmed
Direct human aging trial data?	No — no human interventional data on NHEJ restoration needs-human-replication

Connection to the DDR and senescence

NHEJ failure at unresolvable breaks activates the dna-damage-response (DDR) checkpoint, including atm-mediated phosphorylation of H2AX and activation of p53. Persistent DDR signaling drives the senescence-associated secretory phenotype (SASP) — even in cells with non-lethal, irreparable DSBs that have halted NHEJ. The coupling of NHEJ failure → persistent γ-H2AX → p53-mediated senescence is a central mechanistic thread linking DNA repair with cellular-senescence and the genomic-instability hallmark ⁶.

Role in V(D)J recombination and immunosenescence

NHEJ is the obligate repair pathway for v-d-j-recombination — programmed DSBs introduced by RAG1/RAG2 in lymphocyte precursors are resolved exclusively by NHEJ. Deficiency in any NHEJ component ablates adaptive immunity (see Disease section). Age-related reductions in NHEJ efficiency in hematopoietic stem cells may contribute to reduced B and T cell production and impaired immune repertoire diversity in aged organisms, a component of immunosenescence unsourced — specific mechanistic evidence linking NHEJ decline to V(D)J fidelity in aged HSCs requires primary citation.

Disease connections

Germline loss-of-function mutations in NHEJ components cause a spectrum of immunodeficiency and radiosensitivity syndromes:

Gene	Syndrome	Key features
LIG4	LIG4 syndrome (OMIM #606593)	Spectrum from hypomorphic (radiosensitivity + leukemia predisposition, without overt immunodeficiency — the original 180BR patient) to severe (microcephaly, growth retardation, pancytopenia, SCID — characterized in later cohorts). The 180BR patient (Riballo 1999) had no overt immunodeficiency and near-normal V(D)J recombination; residual LIG4 activity (hypomorphic R278H allele) was sufficient for lymphocyte development 7. Full syndrome features (microcephaly, pancytopenia) are from subsequent case series unsourced — add O’Driscoll 2001 (Nat Genet) citation for the broader syndrome.
DCLRE1C (Artemis)	Artemis-SCID	T−B−NK+ SCID; radiation-sensitive; failure of V(D)J recombination hairpin opening
PRKDC (DNA-PKcs)	DNA-PKcs SCID	T−B−NK+ SCID (analogous to the scid mouse mutation); rare in humans
NHEJ1 (XLF/Cernunnos)	XLF deficiency	Microcephaly, growth retardation, immunodeficiency; lymphoma susceptibility
XRCC4	XRCC4 syndrome	Microcephaly, primary immunodeficiency, lymphoma risk; phenotypically overlaps LIG4 syndrome

The Ku70–Ku80 heterodimer is structurally essential but germline null mutations are embryonic lethal in mice; heterozygous Ku80+/− mice show accelerated aging phenotypes including osteopenia and liver pathology, suggesting that NHEJ gene dosage modulates aging biology in mammals needs-replication.

Pharmacological context

No NHEJ-specific geroprotective intervention is in clinical development. DNA-PKcs is an active oncology drug target (kinase inhibitors M3814/peposertinib, AZD7648, CC-115 in phase 1–2 trials for cancer), but these inhibit NHEJ rather than restore it — inappropriate as aging interventions. Strategies to enhance NHEJ capacity in aged cells remain a conceptual research direction rather than a validated target ¹.

dose-response-unclear — No dose-response data for any NHEJ-modulating agent in an aging context. long-term-unknown — Whether partial restoration of NHEJ activity in aged mice extends lifespan or healthspan has not been tested.

Cross-references

• dna-damage-response — upstream DDR pathway that recruits NHEJ machinery
• atm — activates at DSBs; cross-talks with DNA-PKcs; MRN complex upstream of both
• homologous-recombination — R19 batch sister pathway; competes with NHEJ in S/G2
• ku70-ku80 — R19 batch; Ku heterodimer protein page
• dna-pkcs — R19 batch; catalytic kinase of the DNA-PK holoenzyme
• genomic-instability — hallmark page; NHEJ failure is a central contributor
• cellular-senescence — downstream consequence of persistent NHEJ failure
• p53 — activated by persistent DSBs when NHEJ resolution fails
• v-d-j-recombination — implicit stub; NHEJ is the obligate DSB repair pathway for lymphocyte receptor diversification

Limitations and gaps

• #gap/needs-human-replication — Direct evidence for NHEJ activity decline in human aging (rather than rodent models or in-vitro senescent cells) is limited; Sedelnikova 2004 provides the strongest human-cell link but is in fibroblast culture.
• #gap/no-mechanism — The molecular basis of NHEJ decline with age (reduced Ku expression? post-translational regulation? chromatin compaction at break sites?) is incompletely understood.
• #gap/needs-replication — PAXX’s specific contribution to mammalian NHEJ fidelity in vivo is not yet well-characterized and functional redundancy with XLF is disputed.
• #gap/unsourced — The claim that age-related NHEJ decline in HSCs impairs V(D)J recombination efficiency requires a dedicated primary citation.
• #gap/long-term-unknown — Whether pharmacological restoration of NHEJ extends mammalian lifespan or healthspan has never been tested.
• #gap/unsourced — The disease table entry for full LIG4 syndrome features (microcephaly, growth retardation, pancytopenia) is not sourced to Riballo 1999 (which describes a hypomorphic patient without these features). The full syndrome was characterized by O’Driscoll et al. 2001 (Nat Genet 26:397–400) — add this citation.
• #gap/no-fulltext-access — Mahaney 2009 (10.1042/BJ20080413) download failed despite green OA status; claims in Steps 2–3 (DNA-PKcs autophosphorylation clusters, XRCC4–LIG4–XLF scaffold) attributed to this review are unverified. Retry download or verify via an alternative route.
• The Ju 2006/2007 NHEJ-aging citation suggested in the seeding request (10.1101/sqb.2007.71.001) does not resolve in the archive; the Cold Spring Harbor Symposia DOI format is suspect. The aging/NHEJ claim in this page is instead supported by Sedelnikova 2004 (γ-H2AX persistence) and Sharma 2007 (neuronal NHEJ decline). The Ju reference should be independently verified by the wiki-verifier before use.

Footnotes

Footnotes

1. doi:10.1146/annurev.biochem.052308.093131 · Lieber MR · Annual Review of Biochemistry 2010 · review · 2400+ citations · model: human/biochemical · authoritative mechanistic review of all NHEJ steps; local PDF: not downloaded (not_oa) ↩ ↩² ↩³ ↩⁴ ↩⁵

2. doi:10.1042/BJ20080413 · Mahaney BL, Meek K, Lees-Miller SP · Biochemical Journal 2009 · review · 690 citations · model: human/biochemical · covers DSB recognition through ligation with structural detail; download status: failed (green OA but no viable PDF URL found by the downloader) no-fulltext-access — claims in Steps 2–3 attributed to this source have not been verified against the PDF ↩ ↩² ↩³

3. doi:10.1038/35088000 · Walker JR, Corpina RA, Goldberg J · Nature 2001 · in-vitro (X-ray crystallography) · 1165 citations · model: human Ku70/Ku80 heterodimer (full-length Ku70 + truncated Ku80 lacking C-terminal 19K DNA-PKcs recruitment domain) · 2.5 Å resolution (DNA-bound), 2.7 Å (apo) · confirms: preformed ring encircling DNA; cradles ~two turns of DNA (70 Å binding groove); encircles only central 3–4 bp; no base contacts; Ku70 proximal to free DNA end; inward translocation is rate-limiting for internal DNA binding · local PDF: ↩ ↩² ↩³

4. doi:10.1074/jbc.TM117.000374 · Pannunzio NR, Watanabe G, Lieber MR · Journal of Biological Chemistry 2018 · review · 478 citations · model: human/biochemical · covers XLF·XRCC4·LIG4 complex and LIG4 insert1 mechanism; download status: pending ↩ ↩² ↩³

5. doi:10.1016/j.brainresbull.2007.02.001 · Sharma S · Brain Research Bulletin 2007 · in-vitro (primary cell culture) · model: rat neurons (postnatal, adult, old) · NHEJ activity progressively declines from postnatal to old brain; wortmannin-sensitive (DNA-PKcs-dependent); local PDF: not downloaded (not_oa) ↩

6. doi:10.1038/ncb1095 · Sedelnikova OA et al. · Nature Cell Biology 2004 · in-vitro + in-vivo · n not reported · model: human fibroblasts (replicative senescence) + aged mice (liver, spleen) · demonstrates persistent γ-H2AX foci correlating with unrepairable DSBs in senescent human cells and aged mouse tissues; local PDF: not downloaded (not_oa) ↩ ↩²

7. doi:10.1016/s0960-9822(99)80311-x · Riballo E, Critchlow SE, Teo S-H et al. · Current Biology 1999 · case report + in-vitro · n=1 patient (180BR cell line, acute lymphoblastic leukemia patient, age 14 at diagnosis) · model: human LIG4 hypomorph (R278H mutation, homozygous or hemizygous) · first identification of a LIG4 defect in a human; patient had pronounced radiosensitivity but no overt immunodeficiency and near-normal V(D)J recombination; residual LIG4 adenylation activity detected at high ATP concentrations · PDF: locally available ↩